Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gulf States Advisory (GSA) is a specialized strategic consulting and market access firm dedicated to the life sciences sector in the Middle East and North Africa (MENA) region. The company provides a range of services designed to help international pharmaceutical, biotechnology, and medical device companies successfully enter and navigate the complex healthcare markets of the Gulf Cooperation Council (GCC). GSA's core offerings include regulatory affairs management, pricing and reimbursement strategy, and commercial partnership development. They also specialize in managing Named Patient Programs and early access schemes, ensuring that innovative therapies reach patients in the region before full commercial launch. By leveraging deep local expertise and a robust network of regional stakeholders, Gulf States Advisory facilitates the expansion of global healthcare innovators into high-growth emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gulf States Advisory.